BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34124806)

  • 21. Prognostic significance of tumor budding thresholds in oral tongue squamous cell carcinoma.
    Mascitti M; Togni L; Caponio VCA; Zhurakivska K; Lo Muzio L; Rubini C; Santarelli A; Troiano G
    Oral Dis; 2023 Jul; 29(5):1947-1958. PubMed ID: 35316866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic role of the pre-treatment neutrophil to lymphocyte ratio (NLR) and tumor depth of invasion (DOI) in early-stage squamous cell carcinomas of the oral tongue.
    Salzano G; Dell'Aversana Orabona G; Abbate V; Vaira LA; Committeri U; Bonavolontà P; Piombino P; Maglitto F; Russo C; Russo D; Varricchio S; Attanasi F; Turri-Zanoni M; de Riu G; Califano L
    Oral Maxillofac Surg; 2022 Mar; 26(1):21-32. PubMed ID: 34106358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small oral tongue cancers (≤ 4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cancer.
    Almangush A; Mäkitie AA; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Coletta RD; Salo T; Leivo I
    Virchows Arch; 2018 Oct; 473(4):481-487. PubMed ID: 30039390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomogram based on clinical characteristics and serological inflammation markers to predict overall survival of oral tongue squamous cell carcinoma patient after surgery.
    Lin YW; Kang WP; Huang BL; Qiu ZH; Wei LF; Zhang B; Ding TY; Luo Y; Liu CT; Chu LY; Guo HP; Xu YW; Peng YH
    BMC Oral Health; 2021 Dec; 21(1):667. PubMed ID: 34961504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer.
    Li H; Zhang J; Chen SW; Liu LL; Li L; Gao F; Zhuang SM; Wang LP; Li Y; Song M
    J Transl Med; 2015 Jun; 13():198. PubMed ID: 26094024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.
    Huang Z; Lu Y; Wang W; Xie N; Yi C; Xiong G; Xu X; Zhang M; Wang C
    J Oral Pathol Med; 2023 May; 52(5):372-380. PubMed ID: 36135715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma.
    Mascitti M; Zhurakivska K; Togni L; Caponio VCA; Almangush A; Balercia P; Balercia A; Rubini C; Lo Muzio L; Santarelli A; Troiano G
    Histopathology; 2020 Nov; 77(5):810-822. PubMed ID: 32633006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stage.
    Sridharan S; Thompson LDR; Purgina B; Sturgis CD; Shah AA; Burkey B; Tuluc M; Cognetti D; Xu B; Higgins K; Hernandez-Prera JC; Guerrero D; Bundele MM; Kim S; Duvvuri U; Ferris RL; Gooding WE; Chiosea SI
    Cancer; 2019 Sep; 125(18):3198-3207. PubMed ID: 31174238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathologic grading and its relationship with outcome in oral tongue squamous cell carcinoma.
    Silva LABD; Lopes MLDS; Sá MC; de Almeida Freitas R; Coletta RD; da Silveira EJD; da Costa Miguel MC
    J Oral Pathol Med; 2021 Feb; 50(2):183-190. PubMed ID: 33151566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of depth of invasion to survival outcomes and patterns of recurrence for T3 oral tongue squamous cell carcinoma.
    Newman M; Dziegielewski PT; Nguyen NTA; Seikaly HS; Xie M; O'Connell DA; Harris JR; Biron VL; Gupta MK; Archibald SD; Jackson BS; Young JEM; Keyes KJ; Nichols DS; Zhang H
    Oral Oncol; 2021 May; 116():105195. PubMed ID: 33618103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma.
    Lee SJ; Choi JY; Lee HJ; Baek CH; Son YI; Hyun SH; Moon SH; Kim BT
    Korean J Radiol; 2012; 13(6):752-9. PubMed ID: 23118574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral tongue carcinoma: prognostic changes according to the updated 2020 version of the AJCC/UICC TNM staging system.
    Tagliabue M; De Berardinis R; Belloni P; Gandini S; Scaglione D; Maffini F; Mirabella RA; Riccio S; Gioacchino G; Bruschini R; Chu F; Ansarin M
    Acta Otorhinolaryngol Ital; 2022 Apr; 42(2):140-149. PubMed ID: 35612505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
    Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
    J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-risk human papilloma virus was not detected in a Norwegian cohort of oral squamous cell carcinoma of the mobile tongue.
    Søland TM; Bjerkli IH; Georgsen JB; Schreurs O; Jebsen P; Laurvik H; Sapkota D
    Clin Exp Dent Res; 2021 Feb; 7(1):70-77. PubMed ID: 33140903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Portrait of Oral Tongue Squamous Cell Carcinoma Shown by Integrative Meta-Analysis of Expression Profiles with Validations.
    Thangaraj SV; Shyamsundar V; Krishnamurthy A; Ramani P; Ganesan K; Muthuswami M; Ramshankar V
    PLoS One; 2016; 11(6):e0156582. PubMed ID: 27280700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Prognostic Model Generated from an Apparent Diffusion Coefficient Ratio Reliably Predicts the Outcomes of Oral Tongue Squamous Cell Carcinoma.
    Cai L; Li X; Wu L; Wang B; Si M; Tao X
    Curr Oncol; 2022 Nov; 29(12):9031-9045. PubMed ID: 36547122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
    Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
    Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stage-Specific Survival in Young Patients With Oral Tongue Squamous Cell Carcinoma.
    Bommakanti KK; Abiri A; Han AY; Goshtasbi K; Kuan EC; St John MA
    Otolaryngol Head Neck Surg; 2023 Mar; 168(3):398-406. PubMed ID: 35700039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 15-Gene Signature and Prognostic Nomogram for Predicting Overall Survival in Non-Distant Metastatic Oral Tongue Squamous Cell Carcinoma.
    Liu M; Tong L; Liang B; Song X; Xie L; Peng H; Huang D
    Front Oncol; 2021; 11():587548. PubMed ID: 33767977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple novel prognostic model for early stage oral tongue cancer.
    Almangush A; Coletta RD; Bello IO; Bitu C; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Soini Y; Kosma VM; Koivunen P; Kowalski LP; Nieminen P; Grénman R; Leivo I; Salo T
    Int J Oral Maxillofac Surg; 2015 Feb; 44(2):143-50. PubMed ID: 25457829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.